Results 31 to 40 of about 38,854 (186)
Archives of Endocrinology and Metabolism, 2022 “What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no
Hiroshi Arima +10 more
doaj +1 more source
Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration [PDF]
, 2014 Cisplatin is a highly emetogenic cancer chemotherapy agent, which is often used to induce nausea and emesis in animal models. The cytotoxic properties of cisplatin also cause adverse events that negatively impact on animal welfare preventing repeated ...
A Tidholm +46 more
core +3 more sources
Hyponatremia, Arginine Vasopressin Dysregulation, and Vasopressin Receptor Antagonism [PDF]
American Journal of Nephrology, 2006 Hyponatremia is often associated with arginine vasopressin (AVP) dysregulation that is regulated by the hypothalamo-neurohypophyseal tract in response to changes in plasma osmolality, commonly in patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Amit, Rai +3 more
openaire +2 more sources
Molecules, 2023 Arginine, due to the guanidine moiety, increases peptides’ hydrophilicity and enables interactions with charged molecules, but at the same time, its presence in a peptide chain might reduce its permeability through biological membranes.
Mladena Glavaš +9 more
doaj +1 more source
New Topics in Vasopressin Receptors and Approach to Novel Drugs: Vasopressin and Pain Perception
Journal of Pharmacological Sciences, 2009 Arginine vasopressin (AVP) activates three vasopressin receptors and it also has an agonistic activity on the oxytocin receptor. For an accurate description of the target receptor subtype(s) responsible for complex AVP and oxytocin actions, a careful ...
Taka-aki Koshimizu, Gozoh Tsujimoto
doaj +1 more source
Journal of Pharmacological Sciences, 2009 Arginine vasopressin (AVP) receptors have been classified into V1a, V1b, and V2 subtypes. Recent studies have demonstrated the involvement of AVP in anti-nociception and in morphine-induced anti-nociception.
Kenji Honda, Yukio Takano
doaj +1 more source
Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts [PDF]
, 2015 Aim of this study was to investigate the involvement of the mitochondrial permeability transition pore (MPTP) and oxidative stress in the cardioprotective effect of vasopressin (AVP) on ischemia/reperfusion (I/R) injury.
Azizi, Y. +7 more
core +1 more source
Ожирение и метаболизм, 2010 Central diabetes insipidus (CDI) - a severe disease with disturbance of arginine vasopressin secretion, with excretion of large amounts of hypotonic urine, which leads to dehydration and thirst.
doaj +1 more source
A three-year-old boy with hypodipsic hypernatremia syndrome
The Pan African Medical Journal, 2018 We describe a three-year-old boy who had a growth and psychomotor retardation associated with inappropriate lack of thirst and vasopressin secretion in the presence of chronic plasma hyperosmolarity.
Bousayna Iraqi +3 more
doaj +1 more source
The inositol Inpp5k 5-phosphatase affects osmoregulation through the vasopressin-aquaporin 2 pathway in the collecting system [PDF]
, 2018 Inositol Inpp5k (or Pps, SKIP) is a member of the inositol polyphosphate 5-phosphatases family with a poorly characterized function in vivo. In this study, we explored the function of this inositol 5-phosphatase in mice and cells overexpressing the 42 ...
Beauwens, Renaud +13 more
core